Chronic Pain News and Research

RSS

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.

15 Nov 2013

Radiofrequency neurotomy may be successful alternative treatment for knee osteoarthritis

Chronic knee osteoarthritis is the deterioration of articular cartilage and is one of the most common diseases of aging. Millions of Americans have been diagnosed with knee osteoarthritis. OA often results in pain, restricted movement, sleep disturbance, and functional disability.

14 Nov 2013

Novel study explores effects of meditation on the heart and vascular system

Demystifying meditation with science, researchers at the Scripps Translational Science Institute have teamed with The Chopra Foundation and The Chopra Center for Wellbeing in a novel study of the ancient practice that uses wireless health sensors to collect physiological data from meditators.

14 Nov 2013

People suffering from chronic pain, emotional distress likely to receive long-term opioid therapy

People suffering from chronic non-cancer pain and severe emotional distress, such as depression, anxiety and substance use, are likely to receive long-term opioid therapy despite a lack of evidence that this treatment helps, reports a new review in General Hospital Psychiatry.

13 Nov 2013

Studies suggest novel therapies for nicotine, heroin and gambling addiction

Studies released today suggest promising new treatments for nicotine and heroin addiction, and further our understanding of pathological gambling and heroin abuse in those suffering chronic pain.

12 Nov 2013

Hebrew University to participate in new European research project on chronic pain

The Hebrew University of Jerusalem is one of 11 universities, medical centers and research institutes in seven countries participating in ncRNAPain, a new European research project that aims at further exploring the biological mechanisms underlying chronic pain.

12 Nov 2013

Zalicus announces top-line results from Z160 Phase 2 clinical studies in chronic pain indications

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced top-line results from two Phase 2 clinical studies of Z160 in chronic pain indications.

11 Nov 2013

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.

11 Nov 2013

Tel Aviv University researchers study long-term effects of torture on human pain system

Israeli soldiers captured during the 1973 Yom Kippur War were subjected to brutal torture in Egypt and Syria. Held alone in tiny, filthy spaces for weeks or months, sometimes handcuffed and blindfolded, they suffered severe beatings, burns, electric shocks, starvation, and worse.

6 Nov 2013

Early-life stress suspected to contribute to development of chronic pain in adulthood

Childhood neglect and abuse, whether physical or psychological, confers a lifetime vulnerability to stress, anxiety, and mood problems. Such early-life stress is also suspected to contribute to the development of chronic pain in adulthood.

6 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

High-definition transcranial direct current stimulation helps treat pain in fibromyalgia patients

Imagine significantly reducing a persistent migraine or fibromyalgia by a visit to a doctor who delivers low doses of electricity to the brain.

30 Oct 2013

Physiological processes in soft tissue pain explored using PET imaging

Physiological processes in soft tissue pain such as chronic tennis elbow can be explored using diagnostic imaging methods. This is demonstrated by researchers from Uppsala University and the results are now being published in the prestigious journal PLOS ONE.

29 Oct 2013

Study shows mindfulness-oriented intervention may reduce chronic pain in adults

A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.

23 Oct 2013

Arthritis Society launches campaign to urge Canadians to speak up, "Share The Pain"

The Arthritis Society today launched a nationwide campaign to urge Canadians to speak up and "Share The Pain" they experience in living with arthritis. The Society is aiming to change the conversation about arthritis and trigger a candid, national discussion on the reality of a disease that affects millions of Canadians of every age.

21 Oct 2013

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.

19 Oct 2013

Boston Medical Center receives 2 research awards from PCORI to study delivery of cancer care

Boston Medical Center (BMC) has been approved to receive two research awards from the Patient-Centered Outcomes Research Institute (PCORI). One will study the delivery of cancer care to patients who face socio-legal barriers and the other will test the effectiveness of integrative medical group visits (IMGV) for treating chronic pain.

19 Oct 2013

NIH funding helps develop chronic-pain network to accelerate research, treatments

What do migraine, irritable bowel syndrome, fibromyalgia and rheumatoid arthritis have in common? All involve chronic pain.

17 Oct 2013

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

The impact of bariatric surgery on risk factors for cardiovascular disease depends on a variety of factors, including the type of surgery, sex of the patient, ethnic background, and pre-surgery body mass index, according to a Kaiser Permanente study published today in Annals of Surgery.

16 Oct 2013

Brain damage treatment could be as close as the wardrobe

For those with brain damage or neurological disorders - such as MS or Parkinson's - treatment could be as close as the wardrobe.